Candorium Free Members
Join Candorium to access the full article and more
Free Member Benefits:
✔
Comment & Reply✔
Newsletter Access✔
Follow Authors✔
Share via SMS Go Back
Moderna sues Pfizer/BioNTech for Covid-19 vaccine patent infringement
By Shubhangi Mathur - Aug 26, 2022, 04:06 PM ET
Last Updated - Jun 25, 2024, 01:02 AM EDT
Moderna Inc (NASDAQ: MRNA) sued Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) alleging that the companies have copied its Covid-19 vaccine technology that Moderna developed years before the pandemic
Moderna Inc (NASDAQ: MRNA) sued Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) alleging that the companies have copied its Covid-19 vaccine technology that Moderna developed years before the pandemic.
The lawsuit was being filed in US District Court in Massachusetts and the Regional Court of Dusseldorf in Germany.
Sponsored
Moderna had patented mRNA technology between 2010 and 2016, a lot earlier than the emergence of Covid-19. The company alleges that Pfizer/BioNTech copied its mRNA technology without permission.
Moderna and Pfizer were the two Covid-19 vaccines that got approval in the US early in the pandemic.
Picture Credits: Getty Images
ALSO READ:
Sponsored
Read More from Market Analysis
Read More from Investing
Popular News
Latest News